@misc{indiciae74676cf4558e,
  title = {The hexosamine biosynthesis pathway is a targetable liability in lung cancers with concurrent KRAS and LKB1 mutations.},
  author = {Kim, J. and Cai, F. and Ko, B. and Yang, C. and Lee, H. M. and Muhammad, N. and Li, K. and Haloul, M. and Gu, W. and Faubert, B. and Kaushik, A. K. and Cai, L. and Kasiri, S. and Marriam, U. and Nham, K. and Girard, L. and Wang, H. and Sun, X. and Minna, J. and Unsal-Kacmaz, K. and DeBerardinis, R. J.},
  year = {2020},
  doi = {10.1101/2020.04.13.039669},
  url = {https://www.biorxiv.org/content/10.1101/2020.04.13.039669v1},
  note = {Source identifier: 10.1101/2020.04.13.039669}
}